Unknown

Dataset Information

0

14-3-3? stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion.


ABSTRACT: The protein 14-3-3? (stratifin) is frequently described as a tumor suppressor silenced in about 80% of breast tumors. Intriguingly, we show that 14-3-3? expression, which in normal breast is localized to the myoepithelial cells, tracks with malignant phenotype in two models of basal-like breast cancer progression, and in patients, it is associated with basal-like subtype and poor clinical outcome. We characterized a mechanism by which 14-3-3? guides breast tumor invasion by integrating cytoskeletal dynamics: it stabilizes a complex of solubilized actin and intermediate filaments to maintain a pool of "bioavailable" complexes for polarized assembly during migration. We show that formation of the actin/cytokeratin/14-3-3? complex and cellular migration are regulated by PKC?-dependent phosphorylation, a finding that could form the basis for intervention in aggressive breast carcinomas expressing 14-3-3?. Our data suggest that the biology of this protein is important in cellular movement and is contingent on breast cancer subtype.

SUBMITTER: Boudreau A 

PROVIDER: S-EPMC3799319 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

14-3-3σ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion.

Boudreau Aaron A   Tanner Kandice K   Wang Daojing D   Geyer Felipe C FC   Reis-Filho Jorge S JS   Bissell Mina J MJ  

Proceedings of the National Academy of Sciences of the United States of America 20130925 41


The protein 14-3-3σ (stratifin) is frequently described as a tumor suppressor silenced in about 80% of breast tumors. Intriguingly, we show that 14-3-3σ expression, which in normal breast is localized to the myoepithelial cells, tracks with malignant phenotype in two models of basal-like breast cancer progression, and in patients, it is associated with basal-like subtype and poor clinical outcome. We characterized a mechanism by which 14-3-3σ guides breast tumor invasion by integrating cytoskele  ...[more]

Similar Datasets

| S-EPMC2935210 | biostudies-literature
| S-EPMC3163294 | biostudies-literature
| S-EPMC5840354 | biostudies-literature
| S-EPMC6483650 | biostudies-literature
| S-EPMC3244446 | biostudies-literature
| S-EPMC5095053 | biostudies-literature
| S-EPMC7761676 | biostudies-literature
| S-EPMC4484851 | biostudies-literature
| S-EPMC5597967 | biostudies-literature
2021-06-15 | GSE163257 | GEO